Cargando…

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy

BACKGROUND: Systemic inflammation appears to play a role in the progression of numerous solid tumors by promoting tumor proliferation. Our current study aimed to evaluate the role of inflammatory markers in limited disease (LD) small-cell lung cancer (SCLC) patients undergoing thoracic chemoradiothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernhardt, Denise, Aufderstrasse, Sophie, König, Laila, Adeberg, Sebastian, Bozorgmehr, Farastuk, Christopoulos, Petros, Shafie, Rami A El, Hörner-Rieber, Juliane, Kappes, Jutta, Thomas, Michael, Herth, Felix, Steins, Martin, Debus, Jürgen, Rieken, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280890/ https://www.ncbi.nlm.nih.gov/pubmed/30555261 http://dx.doi.org/10.2147/CMAR.S180990

Ejemplares similares

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy
por: Fink, Christoph A., et al.
Publicado: (2023)

Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Administration Rates
por: Eichkorn, Tanja, et al.
Publicado: (2020)

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Parenchymal and Functional Lung Changes after Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer—Experiences from a Single Institution
por: Hörner-Rieber, Juliane, et al.
Publicado: (2017)

Whole brain radiation therapy alone versus radiosurgery for patients with 1–10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial
por: Bernhardt, Denise, et al.
Publicado: (2018)

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Establishing stereotactic body radiotherapy with flattening filter free techniques in the treatment of pulmonary lesions - initial experiences from a single institution
por: Rieber, Juliane, et al.
Publicado: (2016)

Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients
por: von Eiff, Damian, et al.
Publicado: (2020)

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series
por: Bernhardt, Denise, et al.
Publicado: (2018)

Outcome after Radiotherapy for Vestibular Schwannomas (VS)—Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy
por: Küchler, Maike, et al.
Publicado: (2022)

Metformin Enhanced in Vitro Radiosensitivity Associates with G2/M Cell Cycle Arrest and Elevated Adenosine-5’-monophosphate-activated Protein Kinase Levels in Glioblastoma
por: Adeberg, Sebastian, et al.
Publicado: (2017)

Palliative Radiotherapy for Leptomeningeal Carcinomatosis–Analysis of Outcome, Prognostic Factors, and Symptom Response
por: El Shafie, Rami A., et al.
Publicado: (2019)

Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis
por: El Shafie, Rami A, et al.
Publicado: (2019)

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?
por: Adeberg, Sebastian, et al.
Publicado: (2016)

Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas
por: Rieber, Juliane, et al.
Publicado: (2015)

Effectiveness and Toxicity of Fractionated Proton Beam Radiotherapy for Cranial Nerve Schwannoma Unsuitable for Stereotactic Radiosurgery
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Adjuvant Radiation Therapy for Male Breast Cancer—A Rare Indication?
por: Forster, Tobias, et al.
Publicado: (2020)

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
por: El Shafie, Rami A., et al.
Publicado: (2020)

Single-Isocenter Volumetric Modulated Arc Therapy vs. CyberKnife M6 for the Stereotactic Radiosurgery of Multiple Brain Metastases
por: El Shafie, Rami A., et al.
Publicado: (2020)

Second breast conserving therapy after ipsilateral breast tumor recurrence – a 10-year experience of re-irradiation
por: Forster, Tobias, et al.
Publicado: (2019)

Stereotactic radiotherapy of brain metastases: clinical impact of three-dimensional SPACE imaging for 3T-MRI-based treatment planning
por: Welzel, Thomas, et al.
Publicado: (2022)

Retrospective analysis of outcome and toxicity after postoperative radiotherapy in patients with squamous cell carcinoma of the lip
por: Lang, Kristin, et al.
Publicado: (2021)

Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma
por: König, Laila, et al.
Publicado: (2020)

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
por: Regnery, Sebastian, et al.
Publicado: (2020)

Treatment of meningioma and glioma with protons and carbon ions
por: Adeberg, Sebastian, et al.
Publicado: (2017)

Validation of Nine Different Prognostic Grading Indexes for Radiosurgery of Brain Metastases in Breast Cancer Patients and Development of an All-Encompassing Prognostic Tool
por: Weykamp, Fabian, et al.
Publicado: (2020)

Postoperative Radiotherapy for Endometrial Cancer in Elderly (≥80 Years) Patients: Oncologic Outcomes, Toxicity, and Validation of Prognostic Scores
por: Meixner, Eva, et al.
Publicado: (2021)

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
por: Bozorgmehr, Farastuk, et al.
Publicado: (2020)

Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
por: Bozorgmehr, Farastuk, et al.
Publicado: (2023)

DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma
por: Adeberg, Sebastian, et al.
Publicado: (2022)

Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases—Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept
por: El Shafie, Rami A., et al.
Publicado: (2019)

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial
por: Bozorgmehr, Farastuk, et al.
Publicado: (2019)

Screening and Psycho-Oncological Support for Patients With Head and Neck Cancer and Brain Malignancies Before Radiotherapy With Mask Fixation: Results of a Feasibility Study
por: Adeberg, Sebastian, et al.
Publicado: (2021)

Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy
por: Lang, Kristin, et al.
Publicado: (2020)

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy
por: Syed, Mustafa, et al.
Publicado: (2018)

Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung
por: Hoegen, Philipp, et al.
Publicado: (2020)

Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase‐Positive Non‐Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat
por: Hohmann, Nicolas, et al.
Publicado: (2020)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
por: König, Laila, et al.
Publicado: (2020)

Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors
por: Rheinheimer, Stephan, et al.
Publicado: (2020)

Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety
por: Akbaba, Sati, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2ak482pjrv0gnq7sq9mc9ohe68